Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL
· Real-Time Price · USD
1.33
-0.01 (-0.75%)
At close: Aug 15, 2025, 3:07 PM
Cardiol Therapeutics Cash Flow Statement
Financials in CAD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.29M | -8.18M | -12.73M | -6.59M | -9.18M | -7.64M | -5.93M | -7.47M | -7.09M | -7.52M | -7.97M | -6.49M | -8.95M | -6.26M | -9.91M | -6.56M | -8.91M |
Depreciation & Amortization | 24.99K | 48.49K | 201.09K | 61.91K | 61.62K | 66.76K | 64.89K | 58.5K | 58.2K | 58.03K | 54.48K | 53.78K | 53.62K | 55.59K | 55.59K | 54.62K | 54.62K |
Stock-Based Compensation | 1.15M | 3.15M | 8.42M | 1.81K | 902.1K | 1.01K | 2.05M | 666.4K | 426.82K | 947.96K | 3.58M | -582.24K | 1.07M | 4.59M | 941.11K | 826.65K | 2.14M |
Other Working Capital | -166.75K | 1.09M | -2.67M | 143.45 | -805.5K | 678.38K | -191.64K | 1.37M | -3.3M | 1.99M | 971.74K | 2.83M | 95.97K | 1.38M | 510.32K | -846.38K | -938.35K |
Other Non-Cash Items | 113.75K | -1.6M | -991.1K | 1.75M | 1.58M | -1.16M | 5.94K | 1.38K | 18.08K | 93.47K | 218.62K | 711.83K | 866.28K | -3.78M | 1.98M | 434.72K | 664.39K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 575.32K | 10.36K | -76.84K | -4.44M | -1.72M | -861.6K | -2.13M | -4.92M | n/a | n/a | n/a |
Change in Working Capital | -151.82K | 990.41K | -2.67M | 203.77 | -31.03K | 1.54M | -181.28K | 1.38M | -3.28M | 1.94M | 943.01K | 2.79M | 73.55K | 1.39M | 552.25K | -828.41K | -1.03M |
Operating Cash Flow | -7.15M | -5.59M | -7.77M | -4.78M | -6.92M | -6.46M | -3.41M | -5.35M | -9.95M | -8.92M | -4.9M | -4.37M | -9.03M | -4.01M | -6.39M | -6.07M | -7.08M |
Capital Expenditures | -11.94K | -6.16K | -7.87K | -3.8K | -3.46K | -10.71K | -5.58K | -3.89K | -44.14K | -47.83K | -9.29K | -2.13K | -15.46K | n/a | -12.92K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -11.94K | -6.16K | -7.87K | -3.8K | -3.46K | -10.71K | -5.58K | -3.89K | -44.14K | -47.83K | -9.29K | -2.13K | -15.46K | n/a | -12.92K | n/a | n/a |
Debt Repayment | -13.84K | -13.84K | -4.62K | -9.23K | -13.84K | -13.84K | -13.84K | -13.84K | -13.84K | -13.84K | -13.84K | -13.27K | -12.98K | -12.98K | -12.98K | -12.98K | -12.98K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 18.7M | n/a | 87.31K | 90.2K | 0.00 | -0.00 | -0.00 | -0.00 | n/a | -0.00 | n/a | n/a | -2.81M | 2.34M | 20.8M | 11.08M |
Financial Cash Flow | -13.84K | 18.69M | -4.62K | 78.08K | 76.35K | -13.84K | -13.84K | -13.84K | -13.84K | -13.84K | -13.84K | -13.27K | -12.98K | 59.25M | 2.33M | 20.79M | 11.06M |
Net Cash Flow | -7.29M | 14.7M | -8.14M | -4.55M | -6.3M | -5.61M | -4.4M | -4.53M | -10M | -6.06M | -4.92M | -4.39M | -9.06M | 55.25M | -4.07M | 14.72M | 3.98M |
Free Cash Flow | -7.17M | -5.6M | -7.78M | -4.78M | -6.93M | -6.48M | -3.42M | -5.36M | -9.99M | -8.97M | -4.91M | -4.38M | -9.04M | -4.01M | -6.4M | -6.07M | -7.08M |